Poor outcome and prolonged persistence of SARS‐CoV‐2 RNA in COVID‐19 patients with haematological malignancies; King's College Hospital experience

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2020-09, Vol.190 (5), p.e279-e282
Hauptverfasser:	Shah, Vallari, Ko Ko, Thinzar, Zuckerman, Mark, Vidler, Jennifer, Sharif, Sobia, Mehra, Varun, Gandhi, Shreyans, Kuhnl, Andrea, Yallop, Deborah, Avenoso, Daniele, Rice, Carmel, Sanderson, Robin, Sarma, Anita, Marsh, Judith, Lavallade, Hugues, Krishnamurthy, Pramila, Patten, Piers, Benjamin, Reuben, Potter, Victoria, Ceesay, M. Mansour, Mufti, Ghulam J., Norton, Sam, Pagliuca, Antonio, Galloway, James, Kulasekararaj, Austin G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Betacoronavirus - metabolism Cohort Studies Coronavirus Infections - blood Coronavirus Infections - etiology Coronavirus Infections - mortality Coronavirus Infections - therapy Correspondence COVID-19 COVID‐19 – Online only Disease-Free Survival Female haematological malignancies Hematologic Neoplasms - blood Hematologic Neoplasms - complications Hematologic Neoplasms - mortality Hematologic Neoplasms - therapy Hematology Humans lymphoid malignancies Male Middle Aged myeloid malignancies Pandemics Pneumonia, Viral - blood Pneumonia, Viral - etiology Pneumonia, Viral - mortality Pneumonia, Viral - therapy Ribonucleic acid RNA RNA, Viral - blood SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 stem cell transplantation Survival Rate Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!